Interchangeability of hepatitis A vaccines for childre
Not Applicable
- Conditions
- Hepatitis A
- Registration Number
- JPRN-UMIN000019797
- Lead Sponsor
- Tokyo Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
acute febrile illness immunodeficiency allergy against vaccine contents history of hepatitis A
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Immunogenicity: Anti-HAV antibody Anti-HAV antibody will be measured on days 0 and 28 after vaccination of HAVRIX720.
- Secondary Outcome Measures
Name Time Method Safety Adverse events will be documented by the sublects.